These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8008526)
1. Concerned about ribavirin recommendations. Pope JF; Besunder JB; Kumar ML; Super DM Pediatrics; 1994 Jul; 94(1):132-3. PubMed ID: 8008526 [No Abstract] [Full Text] [Related]
2. Ribavirin. Red Book Committee recommendations questioned. Wald ER; Dashefsky B Pediatrics; 1994 Apr; 93(4):672-3. PubMed ID: 8134228 [No Abstract] [Full Text] [Related]
3. Red Book recommendations on ribavirin challenged. Zucker AR Pediatrics; 1994 May; 93(5):872-3; author reply 873-4. PubMed ID: 8165107 [No Abstract] [Full Text] [Related]
4. Red Book recommendations on ribavirin challenged. Turner RB Pediatrics; 1994 May; 93(5):873; author reply 873-4. PubMed ID: 8165108 [No Abstract] [Full Text] [Related]
5. Ribavirin. Red Book Committee recommendations questioned. Mitchell I; Joffe A; Newth CJ Pediatrics; 1995 Feb; 95(2):319-20. PubMed ID: 7838661 [No Abstract] [Full Text] [Related]
6. Managing bronchiolitis and respiratory syncytial virus: finding the yellow brick road. Hall CB Arch Pediatr Adolesc Med; 2004 Feb; 158(2):111-2. PubMed ID: 14757601 [No Abstract] [Full Text] [Related]
7. Ribavirin therapy of respiratory syncytial virus infections. Ameratunga SN; Lennon DR; Asher MI; Spinetto H; Anderson B N Z Med J; 1994 May; 107(977):180-2. PubMed ID: 8177576 [No Abstract] [Full Text] [Related]
9. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics; 1996 Jan; 97(1):137-40. PubMed ID: 8545210 [TBL] [Abstract][Full Text] [Related]
10. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443 [TBL] [Abstract][Full Text] [Related]
11. Pediatrics academy updates guidelines on ribavirin use. American Academy of Pediatrics. Am J Hosp Pharm; 1994 Jan; 51(1):25, 31. PubMed ID: 8135258 [No Abstract] [Full Text] [Related]
14. [Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus]. Sánchez-Solís de Querol M; Castillo-Ochando F; Díaz-Torres M; Sayed-Sancho N; Sánchez-Flores F; Pajarón de Ahumada M An Esp Pediatr; 1997 Jul; 47(1):14-6. PubMed ID: 9290254 [TBL] [Abstract][Full Text] [Related]
15. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Chen CH; Lin YT; Yang YH; Wang LC; Lee JH; Kao CL; Chiang BL Pediatr Allergy Immunol; 2008 Mar; 19(2):166-72. PubMed ID: 18257904 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of ribavirin in the treatment of RSV. Cooper KE Pediatr Nurs; 2001; 27(1):95-8. PubMed ID: 12025158 [No Abstract] [Full Text] [Related]
17. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Wendt CH; Hertz MI Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850 [TBL] [Abstract][Full Text] [Related]
19. Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia. Zucker AR; Meadow WL Crit Care Med; 1995 Apr; 23(4):767-72. PubMed ID: 7712769 [TBL] [Abstract][Full Text] [Related]
20. Pre-emptive ribavirin for 'RSV' in BMT. DeVincenzo J Bone Marrow Transplant; 2000 Jul; 26(1):113-4. PubMed ID: 10918415 [No Abstract] [Full Text] [Related] [Next] [New Search]